Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.49
-0.05 (-0.59%)
At close: Dec 20, 2024, 4:00 PM
8.40
-0.09 (-1.06%)
After-hours: Dec 20, 2024, 4:34 PM EST
Zevra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -89.66 | -46.05 | -26.77 | -8.56 | -12.76 | -24.52 | Upgrade
|
| Depreciation & Amortization | 5.53 | 1.01 | 0.94 | 0.26 | 0.27 | 0.3 | Upgrade
|
| Other Amortization | - | - | - | 0.15 | 2.31 | 1.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.16 | 0.01 | 0.08 | 0.25 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 17.66 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.23 | -0.61 | 0.58 | - | - | - | Upgrade
|
| Stock-Based Compensation | 12.85 | 6.18 | 4.52 | 2.74 | 2.69 | 4.41 | Upgrade
|
| Other Operating Activities | 6.31 | -0.1 | -15.25 | 16.13 | 4.93 | -0.58 | Upgrade
|
| Change in Accounts Receivable | 2.14 | -9.08 | -6.77 | 1.05 | -0.71 | -1.73 | Upgrade
|
| Change in Inventory | -4.14 | 0.21 | 0.15 | - | - | - | Upgrade
|
| Change in Accounts Payable | -4.86 | 11.13 | 3.13 | -1.11 | 0.93 | -3.79 | Upgrade
|
| Change in Other Net Operating Assets | 2.5 | 3.63 | 3.09 | -0.3 | 0.16 | 0.39 | Upgrade
|
| Operating Cash Flow | -69.57 | -33.54 | -18.72 | 10.44 | -1.94 | -23.74 | Upgrade
|
| Capital Expenditures | -0.07 | -0.3 | -0.09 | -0.1 | -0.03 | -0.03 | Upgrade
|
| Cash Acquisitions | -30.4 | -30.4 | -14.09 | - | - | - | Upgrade
|
| Investment in Securities | -1.06 | 13.31 | -22.54 | -15.42 | - | 3.26 | Upgrade
|
| Investing Cash Flow | -6.11 | -17.39 | -36.72 | -15.52 | -0.03 | 3.23 | Upgrade
|
| Long-Term Debt Issued | - | 43.69 | 14.07 | - | 0.78 | - | Upgrade
|
| Long-Term Debt Repaid | - | -18.1 | -1.32 | -38.1 | -0.23 | -0.21 | Upgrade
|
| Net Debt Issued (Repaid) | 15.84 | 25.59 | 12.75 | -38.1 | 0.55 | -0.21 | Upgrade
|
| Issuance of Common Stock | 72.57 | 6.32 | 0.32 | 158.24 | 2.3 | 5.45 | Upgrade
|
| Repurchase of Common Stock | - | -3.45 | -4.72 | -2.81 | - | - | Upgrade
|
| Other Financing Activities | -2.09 | - | - | -4.22 | -0.12 | -0.3 | Upgrade
|
| Financing Cash Flow | 86.32 | 28.46 | 8.35 | 113.11 | 2.74 | 4.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.13 | 0.04 | 0.2 | - | - | - | Upgrade
|
| Net Cash Flow | 10.77 | -22.42 | -46.88 | 108.02 | 0.77 | -15.56 | Upgrade
|
| Free Cash Flow | -69.65 | -33.83 | -18.81 | 10.34 | -1.97 | -23.76 | Upgrade
|
| Free Cash Flow Margin | -284.39% | -123.20% | -185.12% | 36.08% | -14.84% | -185.08% | Upgrade
|
| Free Cash Flow Per Share | -1.64 | -0.95 | -0.55 | 0.35 | -0.50 | -12.82 | Upgrade
|
| Cash Interest Paid | 3.67 | 0.46 | 0.32 | 0.22 | 0.08 | 5.36 | Upgrade
|
| Levered Free Cash Flow | 16.58 | -10.32 | -10 | 6.31 | -0.86 | -15.57 | Upgrade
|
| Unlevered Free Cash Flow | 20.27 | -9.39 | -9.79 | 6.39 | 1.27 | -13.16 | Upgrade
|
| Change in Net Working Capital | -56.18 | -14.73 | -0.4 | 1.33 | -1.32 | 5.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.